Lv1
10 积分 2026-05-23 加入
Development and Execution of a Scalable Route to an Immunology ADC Drug-Linker for ABBV-154
22小时前
待确认
Determination of Purge Factors for Use in Oligonucleotide Control Strategies
1天前
已完结
Purge Factor Analysis and Proposal for Non-conjugatable Impurity Clearance in Post-conjugation Purification of ADCs
1天前
已完结
Impurity qualification requirements for drug-linkers related impurities used to generate antibody-drug conjugates
3天前
已完结
Strategies for UF/DF-Based Impurity Removal in the Post-conjugation Purification of Antibody–Drug Conjugates
3天前
已完结
Kinetic Studies of the Partial Reduction and Conjugation Reactions in an Antibody-Drug Conjugate (ADC) Synthesis
5天前
已完结
Development of Commercial-Ready Processes for Antibody Drug Conjugates
5天前
已完结
Drug-Linkers in Antibody–Drug Conjugates: Perspective on Current Industry Practices
5天前
已完结
Synthesis and Impurity Profiling of a Vital Intermediate in Gabapentin and Bispidine Derivative Pathways by Response Surface Methodology
5天前
已完结
Advancing Peptide Synthesis: Liquid-Phase Assembly of Tirzepatide’s C-Terminus (30–39) via Crystalline Pentamer Building Blocks
7天前
已完结
皖公网安备34019202002308
